MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    Development of a remote physical exercise program during COVID-19 pandemic for individuals with Parkinson’s disease

    C. Torriani-Pasin, T. Freitas, V. Domingues, B. Araújo, G. Palma, M. Makhoul, R. Andreotti, L. Mochizuki (Sao Paulo, Brazil)

    Objective: To describe the development process of adaptation of in-person physical exercise program to telemonitoring format to people with Parkinson’s disease (PD). Background: People with…
  • MDS Virtual Congress 2021

    Life Satisfaction and Adaptation in Persons with Parkinson’s Disease

    L. Rosengren, A. Forsberg, C. Brogardh, J. Lexell (Lund, Sweden)

    Objective: This study aimed to gain an in-depth understanding of the meaning of LS and adaptation in persons with PD. Background: Persons with Parkinson’s disease…
  • MDS Virtual Congress 2021

    Development of the Parkinson’s Disease Medication Adherence Scale (PD-MAS)

    M. Tosin, C. Goetz, G. Stebbins, B. Oliveira (Niteroi, Brazil)

    Objective: To implement the first 3 phases of the scale development process that will create the PD-MAS. Background: Drug therapy is a central strategy in…
  • MDS Virtual Congress 2021

    Anodic stimulation reduces corticospinal tract engagement in STN-DBS for Parkinson’s disease: a case report.

    G. Di Rauso, S. Coniglio, A E. Vaudano, F. Cavallieri, A. Puzzolante, A. Feletti, F. Antonelli, S. Meletti, F. Valzania, V. Rispoli (Modena, Italy)

    Objective: To seek how novel programming options modify the therapeutic window in a case of off-targeting DBS. Background: In Parkinson’s disease deep brain stimulation (DBS)…
  • MDS Virtual Congress 2021

    DBS Directional programming – Institution based study of programming in PD and ET patients

    M. Moreno-Escobar, R. Elkins, S. Pallavaram, R. Tripathi (Morgantown, USA)

    Objective: To examine the use of Deep Brain Stimulation (DBS) directional programming in Parkinson Disease (PD) and Essential Tremor (ET) patients Background: DBS and its utility…
  • MDS Virtual Congress 2021

    Metadata standards to support deployment of Digital Health Technologies in Clinical Trials in Parkinson’s Disease (PD)

    D. Hill, D. Stephenson, J. Brayanov, K. Claes, R. Badawy, S. Sardar, K. Fisher, S. Lee, A. Bannon, V. Terebaite, R. Bhatnagar (St Pierre Dechartreuse, France)

    Objective: A metadata framework for Digital Health Technologies (DHT) to support enhanced regulatory maturity, and to facilitate standardization and harmonization of data collection Background: DHTs…
  • MDS Virtual Congress 2021

    Effect of dopaminergic treatment on digital sensor features in Phase II PASADENA Part 1 in early Parkinson’s disease

    B. van Lier, J. Anzures Cabrera, E. Volkova-Volkmar, L. Essioux, H. Svoboda, W. Zago, G. Pagano, R. Postuma, M. Lindemann, K. Taylor, F. Lipsmeier (Basel, Switzerland)

    Objective: To characterize the sensitivity of smartphone and -watch sensor features to levodopa and dopamine agonist (DA-Tx) treatment. Background: Digital health technology tools (DHTTs) enable…
  • MDS Virtual Congress 2021

    Determining the content of a clinician-rated tool for freezing of gait severity

    A. Scully, B. de Oliveira, K. Hill, D. Tan, YH. Pua, R. Clark, E. Burton (Bentley, Australia)

    Objective: This study aimed to determine clinician’s ratings of the most important triggering circumstances to be examined and aspects of freezing of gait (FOG) to…
  • MDS Virtual Congress 2021

    Diagnostic accuracy in an incidence cohort of Parkinson’s disease

    B. Brownlee, C. Counsell, A. Macleod (Aberdeen, United Kingdom)

    Objective: To determine the accuracy of clinical diagnosis and research diagnostic criteria in a population-representative cohort of Parkinson's disease (PD) against a neuropathological gold standard…
  • MDS Virtual Congress 2021

    The COVID-19 Pandemic Impact on Advanced Parkinson’s Disease in the US

    D. Oleske, S. Talapala, P. Kukreja, M. Facheris, R. Dorsey, S. Dey, A. Isherwood (North Chicago, USA)

    Objective: Characterize the risk of seven acute medical events in persons with advanced Parkinson’s disease (PD) using real world data before and within 12 months…
  • « Previous Page
  • 1
  • …
  • 394
  • 395
  • 396
  • 397
  • 398
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • An atypical and interesting feature of Parkinson´s disease
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley